vs
Side-by-side financial comparison of SEMTECH CORP (SMTC) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $267.0M, roughly 1.1× SEMTECH CORP). Bio-Techne runs the higher net margin — 12.8% vs -1.1%, a 13.9% gap on every dollar of revenue. On growth, SEMTECH CORP posted the faster year-over-year revenue change (12.7% vs -6.4%). Over the past eight quarters, SEMTECH CORP's revenue compounded faster (17.6% CAGR vs 4.2%).
Semtech Corporation is an American supplier of analog and mixed-signal semiconductors and advanced algorithms for consumer, enterprise computing, communications and industrial end-markets. It is based in Camarillo, Ventura County, Southern California. It was founded in 1960 in Newbury Park, California. It has 32 locations in 15 countries in North America, Europe, and Asia.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SMTC vs TECH — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $267.0M | $295.9M |
| Net Profit | $-2.9M | $38.0M |
| Gross Margin | 51.9% | 64.6% |
| Operating Margin | 11.6% | 18.4% |
| Net Margin | -1.1% | 12.8% |
| Revenue YoY | 12.7% | -6.4% |
| Net Profit YoY | 62.3% | 68.3% |
| EPS (diluted) | $-0.03 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $267.0M | $295.9M | ||
| Q3 25 | $257.6M | — | ||
| Q2 25 | $251.1M | $317.0M | ||
| Q1 25 | $251.0M | $316.2M | ||
| Q4 24 | $236.8M | $297.0M | ||
| Q3 24 | $215.4M | $289.5M | ||
| Q2 24 | $206.1M | $306.1M | ||
| Q1 24 | $192.9M | $303.4M |
| Q4 25 | $-2.9M | $38.0M | ||
| Q3 25 | $-27.1M | — | ||
| Q2 25 | $19.3M | $-17.7M | ||
| Q1 25 | $39.1M | $22.6M | ||
| Q4 24 | $-7.6M | $34.9M | ||
| Q3 24 | $-170.3M | $33.6M | ||
| Q2 24 | $-23.2M | $40.6M | ||
| Q1 24 | $-642.4M | $49.1M |
| Q4 25 | 51.9% | 64.6% | ||
| Q3 25 | 52.1% | — | ||
| Q2 25 | 52.3% | 62.7% | ||
| Q1 25 | 52.0% | 67.9% | ||
| Q4 24 | 51.1% | 65.3% | ||
| Q3 24 | 49.0% | 63.2% | ||
| Q2 24 | 48.3% | 66.4% | ||
| Q1 24 | -0.2% | 67.4% |
| Q4 25 | 11.6% | 18.4% | ||
| Q3 25 | -6.3% | — | ||
| Q2 25 | 14.3% | -7.5% | ||
| Q1 25 | 8.5% | 12.2% | ||
| Q4 24 | 7.5% | 16.0% | ||
| Q3 24 | 3.6% | 13.8% | ||
| Q2 24 | 1.5% | 15.0% | ||
| Q1 24 | -321.3% | 22.1% |
| Q4 25 | -1.1% | 12.8% | ||
| Q3 25 | -10.5% | — | ||
| Q2 25 | 7.7% | -5.6% | ||
| Q1 25 | 15.6% | 7.1% | ||
| Q4 24 | -3.2% | 11.7% | ||
| Q3 24 | -79.1% | 11.6% | ||
| Q2 24 | -11.2% | 13.3% | ||
| Q1 24 | -332.9% | 16.2% |
| Q4 25 | $-0.03 | $0.24 | ||
| Q3 25 | $-0.31 | — | ||
| Q2 25 | $0.22 | $-0.11 | ||
| Q1 25 | $0.81 | $0.14 | ||
| Q4 24 | $-0.10 | $0.22 | ||
| Q3 24 | $-2.61 | $0.21 | ||
| Q2 24 | $-0.36 | $0.26 | ||
| Q1 24 | $-10.00 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.7M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $565.7M | $2.0B |
| Total Assets | $1.4B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.7M | $172.9M | ||
| Q3 25 | $168.6M | — | ||
| Q2 25 | $156.5M | $162.2M | ||
| Q1 25 | $151.7M | $140.7M | ||
| Q4 24 | $136.5M | $177.5M | ||
| Q3 24 | $115.9M | $187.5M | ||
| Q2 24 | $126.8M | $152.9M | ||
| Q1 24 | $128.6M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $565.7M | $2.0B | ||
| Q3 25 | $552.9M | — | ||
| Q2 25 | $568.8M | $1.9B | ||
| Q1 25 | $542.4M | $2.0B | ||
| Q4 24 | $-139.7M | $2.1B | ||
| Q3 24 | $-141.4M | $2.1B | ||
| Q2 24 | $-313.1M | $2.1B | ||
| Q1 24 | $-307.4M | $2.0B |
| Q4 25 | $1.4B | $2.5B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | $1.4B | $2.7B | ||
| Q2 24 | $1.4B | $2.7B | ||
| Q1 24 | $1.4B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $47.5M | — |
| Free Cash FlowOCF − Capex | $44.6M | — |
| FCF MarginFCF / Revenue | 16.7% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $143.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $47.5M | — | ||
| Q3 25 | $44.4M | — | ||
| Q2 25 | $27.8M | $98.2M | ||
| Q1 25 | $33.5M | $41.1M | ||
| Q4 24 | $29.6M | $84.3M | ||
| Q3 24 | $-5.0M | $63.9M | ||
| Q2 24 | $-89.0K | $75.5M | ||
| Q1 24 | $13.9M | $81.0M |
| Q4 25 | $44.6M | — | ||
| Q3 25 | $41.5M | — | ||
| Q2 25 | $26.2M | $93.3M | ||
| Q1 25 | $30.9M | $31.0M | ||
| Q4 24 | $29.1M | $77.5M | ||
| Q3 24 | $-8.4M | $54.7M | ||
| Q2 24 | $-1.4M | $57.5M | ||
| Q1 24 | $12.2M | $64.5M |
| Q4 25 | 16.7% | — | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 10.4% | 29.4% | ||
| Q1 25 | 12.3% | 9.8% | ||
| Q4 24 | 12.3% | 26.1% | ||
| Q3 24 | -3.9% | 18.9% | ||
| Q2 24 | -0.7% | 18.8% | ||
| Q1 24 | 6.3% | 21.3% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 1.0% | 3.2% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 1.6% | 3.2% | ||
| Q2 24 | 0.6% | 5.9% | ||
| Q1 24 | 0.9% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 0.86× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SMTC
| Products | $239.5M | 90% |
| Services | $27.4M | 10% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
